151 related articles for article (PubMed ID: 7902171)
1. Proliferating cell nuclear antigen in normal urothelium and urothelial lesions of the urinary bladder: a quantitative assessment using a true color image analysis system.
Knuechel R; Burgau M; Rueschoff J; Hofstaedter F
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(3):137-44. PubMed ID: 7902171
[TBL] [Abstract][Full Text] [Related]
2. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
[TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters.
Skopelitou A; Korkolopoulou P; Papanicolaou A; Christodoulou P; Thomas-Tsagli E; Pavlakis K
Eur Urol; 1992; 22(3):235-40. PubMed ID: 1361436
[TBL] [Abstract][Full Text] [Related]
4. [Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].
Offner FA; Schäfer G; Hittmair A; Ofner D; Grünewald K; Weyrer K; Mattern D; Eberle J; Mikuz G; Feichtinger H
Verh Dtsch Ges Pathol; 1993; 77():241-6. PubMed ID: 7511289
[TBL] [Abstract][Full Text] [Related]
5. The expression of proliferating cell nuclear antigen in hepatocellular carcinoma.
Wu JD; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):198-203. PubMed ID: 7911731
[TBL] [Abstract][Full Text] [Related]
6. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
Krüger S; Müller H
Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
[TBL] [Abstract][Full Text] [Related]
7. Analysis of proliferative activity in colorectal mucosa by immunohistochemical detection of proliferating cell nuclear antigen (PCNA). Methodological aspects and application to routine diagnostic material.
Diebold J; Lai MD; Löhrs U
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):283-9. PubMed ID: 1359701
[TBL] [Abstract][Full Text] [Related]
8. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
Serio G
Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
[TBL] [Abstract][Full Text] [Related]
9. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
10. Expression of proliferative cell nuclear antigen (PCNA) in urinary bladder carcinoma. Evaluation of antigen retrieval methods.
Malmström PU; Wester K; Vasko J; Busch C
APMIS; 1992 Nov; 100(11):988-92. PubMed ID: 1361755
[TBL] [Abstract][Full Text] [Related]
11. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal antibodies (MIB 1, PC 10, 486p and p53) as prognostic factors for recurrent urothelial carcinoma of the urinary bladder].
Hake R; Vorreuther R; Borchmann P; Lukowsky S; Thiele J; Fischer R
Verh Dtsch Ges Pathol; 1993; 77():236-40. PubMed ID: 7511288
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in gynecological tumors and their related lesions].
Sawada M; Ueda G; Inoue M; Shimizu H; Ogawa H; Nakazawa A; Fujita M; Tanizawa O; Tsujimoto M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):181-7. PubMed ID: 1347557
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas.
Pich A; Chiusa L; Comino A; Navone R
Virchows Arch; 1994; 424(2):143-8. PubMed ID: 7910097
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evidence for the expression of proliferating cell nuclear antigen (PCNA) by non-proliferating hepatocytes adjacent to metastatic tumours and in inflammatory conditions.
Harrison RF; Reynolds GM; Rowlands DC
J Pathol; 1993 Oct; 171(2):115-22. PubMed ID: 7904308
[TBL] [Abstract][Full Text] [Related]
16. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
Cheville JC; Terrell RB; Cohen MB
Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
[TBL] [Abstract][Full Text] [Related]
17. Expression of proliferating cell nuclear antigen (PCNA) in dysplasia of the bronchial epithelium.
Pendleton N; Dixon GR; Burnett HE; Occleston NL; Myskow MW; Green JA
J Pathol; 1993 Jun; 170(2):169-72. PubMed ID: 8102179
[TBL] [Abstract][Full Text] [Related]
18. Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors.
Cordon-Cardo C; Wartinger DD; Melamed MR; Fair W; Fradet Y
Am J Pathol; 1992 Feb; 140(2):375-85. PubMed ID: 1739131
[TBL] [Abstract][Full Text] [Related]
19. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical investigation of proliferating cell nuclear antigen in bladder cancer].
Sumiyoshi Y; Inoue Y; Akiyama M
Nihon Hinyokika Gakkai Zasshi; 1993 Sep; 84(9):1643-8. PubMed ID: 8105131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
